529NewsUni-Bio Science Group Limited Announces 2022 Annual Results
Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved Expanding Portfolio with New Drug Innovations and Strategic R&D Partnerships HONG...
- 514Wire Stories
New Global Refinery Capacity Caters to High-Demand Hotspots, an Industrial Info News Alert
SUGAR LAND, Texas–(BUSINESS WIRE)–Researched by Industrial Info Resources — Around the world, large-scale refineries are nearing completion after years in the works...
- 454Wire Stories
New Global Refinery Capacity Caters to High-Demand Hotspots, an Industrial Info News Alert
SUGAR LAND, Texas–(BUSINESS WIRE)–Researched by Industrial Info Resources — Around the world, large-scale refineries are nearing completion after years in the works...
- 447Wire Stories
L’Officiel Inc. SAS Granted Permits by the Ministry of Home Affairs of Malaysia to Publish Locally and Achieved Another Milestone Under the Direct Owner’s Model
NEW YORK & HONG KONG & SINGAPORE–(BUSINESS WIRE)–L’Officiel Inc. SAS (“L’Officiel”), a subsidiary of AMTD IDEA Group (NYSE: AMTD; SGX: HKB), announced...
- 442Wire Stories
L’Officiel Inc. SAS Granted Permits by the Ministry of Home Affairs of Malaysia to Publish Locally and Achieved Another Milestone Under the Direct Owner’s Model
NEW YORK & HONG KONG & SINGAPORE–(BUSINESS WIRE)–L’Officiel Inc. SAS (“L’Officiel”), a subsidiary of AMTD IDEA Group (NYSE: AMTD; SGX: HKB), announced...
- 434Wire Stories
OliX Pharmaceuticals Doses First Patient in Clinical Trial for RNAi Therapeutic OLX10212 for Dry and Wet Age-related Macular Degeneration
SUWON, South Korea–(BUSINESS WIRE)–#AMD—OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the first patient has been...
- 515Wire Stories
OliX Pharmaceuticals Doses First Patient in Clinical Trial for RNAi Therapeutic OLX10212 for Dry and Wet Age-related Macular Degeneration
SUWON, South Korea–(BUSINESS WIRE)–#AMD—OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the first patient has been...
- 640Wire Stories
Asia’s Largest Biotech Event, BIO KOREA 2023 to Be Held From May 10 to 12 in Seoul
SEOUL, South Korea–(BUSINESS WIRE)–#BIOKOREA—BIO KOREA 2023, Korea’s top Biotech event representing Asia, will take place from May 10th to 12th at COEX...
- 439Wire Stories
Arizona Sonoran Drills 547 ft (167 m) of 1.14% CuT at Parks/Salyer
CASA GRANDE, Ariz. & TORONTO–(BUSINESS WIRE)–$ASCU #Arizona—Arizona Sonoran Copper Company Inc. (TSX:ASCU | OTCQX:ASCUF) (“ASCU” or the “Company”) infill drilling at the...
- 570Wire Stories
FiscalNote Announces Major New Customer Agreements with International Governments, Embassies, Agencies, Parliaments, and Ministries Across the Global Public Sector
Governments Increasingly Rely on FiscalNote’s Geopolitical, Policy, and Political Intelligence – Powered by AI – For Legislative Tracking, Issue Monitoring, and Critical...
